Source: BNN Bloomberg

GSK: Covid Drugmaker Vir Wins US Pandemic Contract Worth Up to $1 Billion - BNN Bloomberg

Vir Biotechnology Inc., the collaborator with GSK Plc on a Covid-19 treatment, won a multiyear contract to help the US government prepare for future pandemics.

Read full article »
Annual Revenue
$42.3B
Employees
90,096
Dame Emma Walmsley's photo - CEO of GSK

CEO

Dame Emma Walmsley

CEO Approval Rating

67/100

Read more